PR.com
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce that Daniel Claassen, MD, MS, an internationally recognized Huntington’s Disease neurologist and researcher has accepted the role as the organization’s Chief Executive Officer, effective September 1, 2024. Dr. Claassen has been involved with the HSG for over 12 years…
Read More
Huntington Study Group Announces New CEO
Huntington Study Group
21:33
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce that Daniel Claassen, MD, MS, an internationally recognized Huntington’s Disease neurologist and researcher has accepted the role as the organization’s Chief Executive Officer, effective September 1, 2024. Dr. Claassen has been involved with the HSG for over 12 years…
